Acquisition by Matthew Foehr of 225000 shares of OmniAb at 5.19 subject to Rule 16b-3

OABI Stock  USD 3.52  0.07  1.95%   
Under 68% of OmniAb's investor base is looking to short. The analysis of the overall investor sentiment regarding OmniAb Inc suggests that many traders are alarmed. OmniAb's investing sentiment shows overall attitude of investors towards OmniAb Inc.
  
Filed transaction by OmniAb Inc Director, Officer: President And Ceo. Grant, award or other acquisition pursuant to Rule 16b-3(d)

Read at news.google.com
Google News at Macroaxis
  
Acquisition of 225000 common stock at 5.19 of OmniAb by Matthew Foehr on 22nd of March 2024. This event was filed by OmniAb Inc with SEC on 2024-03-22. Statement of changes in beneficial ownership - SEC Form 4

OmniAb Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards OmniAb can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

OmniAb Fundamental Analysis

We analyze OmniAb's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of OmniAb using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of OmniAb based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Price To Sales

Price To Sales Comparative Analysis

OmniAb is currently under evaluation in price to sales category among its peers. Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.

OmniAb Inc Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with OmniAb stock to make a market-neutral strategy. Peer analysis of OmniAb could also be used in its relative valuation, which is a method of valuing OmniAb by comparing valuation metrics with similar companies.

Peers

OmniAb Related Equities

EWTXEdgewise Therapeutics   1.95   
0%
18.0%
VRNAVerona Pharma   1.81   
0%
17.0%
PMVPPmv Pharmaceuticals   1.42   
0%
13.0%
ITOSIteos Therapeutics   1.29   
0%
12.0%
ACETAdicet Bio   1.12   
0%
10.0%
KROSKeros Therapeutics   0.27   
0%
2.0%
IDYAIdeaya Biosciences   0.48   
4.0%
0%
ERASErasca   0.71   
6.0%
0%
IPSCCentury Therapeutics   0.93   
8.0%
0%
GLUEMonte Rosa   1.03   
9.0%
0%
OLMAOlema Pharmaceuticals   1.29   
12.0%
0%
CGEMCullinan Oncology   1.29   
12.0%
0%
LEGNLegend Biotech   1.30   
12.0%
0%
IKNAIkena Oncology   2.14   
20.0%
0%
VORVor Biopharma   3.17   
30.0%
0%
PASGPassage Bio   3.77   
35.0%
0%
BCABBioatla   10.53   
100.0%
0%

Complementary Tools for OmniAb Stock analysis

When running OmniAb's price analysis, check to measure OmniAb's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy OmniAb is operating at the current time. Most of OmniAb's value examination focuses on studying past and present price action to predict the probability of OmniAb's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move OmniAb's price. Additionally, you may evaluate how the addition of OmniAb to your portfolios can decrease your overall portfolio volatility.
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Commodity Directory
Find actively traded commodities issued by global exchanges
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Share Portfolio
Track or share privately all of your investments from the convenience of any device